| CNS | Ophthalmology | Infectious disease | Inflammation | |
| AFG 5 |
Nanofitin® in vivo | |||
| AFG 2 |
AFG 3 |
Nanofitin® optimization | ||
| AFG 1 |
Nanofitin® identification | |||
| AFG 4 |
AFG 6 |
Target selection |
More information about Nanofitin® partnering opportunities?
Please contact inquiries@affilogic.com